Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

“We do not condone these practices and it’s important to understand that for Ozempic, only the marked doses on the pens (0.25 ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo Nordisk's Novolog (insulin ... more than $55 for a box of five pen cartridges – which Civica ...

If you’re on the fence about investing in AbbVie Inc. or Novo Nordisk A/S because you’re ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers ...

If you’re on the fence about investing in Novo Nordisk A/S or Novartis AG because ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...